| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gregory Lip | Q60393087 |
| Yutao Guo | Q90012486 | ||
| Stavros Apostolakis | Q102078427 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| Atrial Fibrillation | Q815819 | ||
| P304 | page(s) | 2263-2270 | |
| P577 | publication date | 2012-12-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Inflammation in atrial fibrillation | |
| P478 | volume | 60 |
| Q33758744 | A Potential Role of Esophageal Cancer Related Gene-4 for Atrial Fibrillation |
| Q48057363 | A comparison of the electrophysiologic and electroanatomic characteristics between the right and left atrium in persistent atrial fibrillation: Is the right atrium a window into the left? |
| Q97643264 | A greater burden of atrial fibrillation is associated with worse endothelial dysfunction in hypertension |
| Q92020742 | Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies |
| Q53820825 | Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model. |
| Q36287597 | Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm |
| Q38747406 | Anti-inflammatory effect of factor-Xa inhibitors in Japanese patients with atrial fibrillation |
| Q58554222 | Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms |
| Q42053459 | Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation |
| Q42438761 | Arrhythmias during and after zoledronic acid infusion patients with bone metastasis. |
| Q38738095 | Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation |
| Q90999427 | Association between Atrial Fibrillation, Myocardial Infarction, Heart Failure and Mortality in Patients with Nontuberculous Mycobacterial Infection: a nationwide population-based study |
| Q47252932 | Association between serum uric acid and atrial fibrillation: a cross-sectional community-based study in China |
| Q64116453 | Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis |
| Q33591227 | Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram |
| Q35605552 | Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression |
| Q36069585 | Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis |
| Q38739817 | Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population. |
| Q36074807 | Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults |
| Q55438072 | Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers. |
| Q59136309 | Atrial Fibrillation Mechanisms and Implications for Catheter Ablation |
| Q36956791 | Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms |
| Q28082470 | Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review |
| Q28074311 | Atrial Fibrillation and Risk of Dementia/Cognitive Decline |
| Q35661109 | Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study |
| Q28072139 | Atrial Fibrillation: The Science behind Its Defiance |
| Q56607936 | Atrial fibrillation |
| Q33970602 | Atrial fibrillation and the risk of myocardial infarction |
| Q36514164 | Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation |
| Q26864877 | Atrial fibrillation: effects beyond the atrium? |
| Q27693290 | Atrial fibrillation: inflammation in disguise? |
| Q28073181 | Atrial fibrillation: review of current treatment strategies |
| Q33589724 | Atrial high-rate episodes and stroke prevention |
| Q38347506 | Atrial remodeling, fibrosis, and atrial fibrillation |
| Q49874468 | Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients |
| Q38880366 | Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: Prospective study and pooled analysis of published evidence |
| Q91726320 | Baseline atrial fibrillation is a risk factor for erectile dysfunction: Systemic review and meta-analysis |
| Q58108235 | Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial Fibrillation |
| Q89577203 | Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study |
| Q38174213 | Biomarkers in atrial fibrillation: an overview |
| Q35805412 | Biomarkers in electrophysiology: role in arrhythmias and resynchronization therapy |
| Q88110640 | Biomarkers of Inflammation, Thrombogenesis, and Collagen Turnover in Patients With Atrial Fibrillation |
| Q38396343 | Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation |
| Q35070863 | Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study |
| Q39100770 | Blood markers of inflammation and endothelial dysfunction in cardioembolic stroke: systematic review and meta-analysis. |
| Q38789345 | C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study. |
| Q38372615 | CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation |
| Q96304899 | COVID-19 and new-onset arrhythmia |
| Q33820434 | Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation |
| Q91519556 | Cardioimmunology: the immune system in cardiac homeostasis and disease |
| Q58791437 | Cardiovascular and inflammatory mechanisms in healthy humans exposed to air pollution in the vicinity of a steel mill |
| Q47119395 | Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis |
| Q58865112 | Characterization of thrombogenic, endothelial and inflammatory markers in supraventricular tachycardia: a study in patients with structurally normal hearts |
| Q37094015 | Circulating Biomarkers Predictive of Postoperative Atrial Fibrillation |
| Q35070617 | Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study |
| Q48940851 | Circulating intermediate CD14++CD16+monocytes are increased in patients with atrial fibrillation and reflect the functional remodelling of the left atrium. |
| Q34479088 | Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort |
| Q41150386 | Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation |
| Q47099909 | Clinical significance of atrial high-rate episodes for thromboembolic events in Japanese population |
| Q90194122 | Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? |
| Q34675561 | Combinatorial release of dexamethasone and amiodarone from a nano-structured parylene-C film to reduce perioperative inflammation and atrial fibrillation |
| Q47721405 | Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease |
| Q91876306 | Comparative proteomic analysis of plasma of children with congenital heart disease |
| Q98466736 | Comparison of Inflammatory Mediators in Patients With Atrial Fibrillation Using Warfarin or Rivaroxaban |
| Q37277429 | Cross-talk between macrophages and atrial myocytes in atrial fibrillation |
| Q48233660 | Diabetes mellitus and atrial remodelling in patients with paroxysmal atrial fibrillation: Role of electroanatomical mapping and catheter ablation |
| Q26800991 | Diagnosing Paroxysmal Atrial Fibrillation: Are Biomarkers the Solution to This Elusive Arrhythmia? |
| Q41686277 | Discordant Relationships between Systemic Inflammatory Markers and Burden of Oxidative Stress in Patients with Atrial Fibrillation |
| Q36940962 | Do preoperative C-reactive protein and mean platelet volume levels predict development of postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting? |
| Q87427790 | Does angiotensin receptor blockade ameliorate the prothrombotic tendency in hypertensive patients with atrial fibrillation? Breaking the vicious cycle |
| Q52687544 | Does atrial fibrillation cause cognitive decline and dementia? |
| Q90319728 | Double or Triple Antithrombotic Treatment in Atrial Fibrillation Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention |
| Q38124873 | ECG abnormalities and stroke incidence |
| Q30375302 | EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. |
| Q55638585 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. |
| Q45939560 | EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. |
| Q37353575 | Effect of Metabolic Syndrome on Risk Stratification for Left Atrial or Left Atrial Appendage Thrombus Formation in Patients with Nonvalvular Atrial Fibrillation |
| Q37615562 | Effect of Shensong Yangxin on the Progression of Paroxysmal Atrial Fibrillation is Correlated with Regulation of Autonomic Nerve Activity |
| Q97519731 | Effect of serum γ-glutamyltranferase and albumin levels on the response to cardiac resynchronization therapy in the elderly |
| Q55105794 | Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation. |
| Q36838268 | Endothelial activation microparticles and inflammation status improve with exercise training in african americans. |
| Q38714286 | Eosinophils in patients with lone atrial fibrillation. |
| Q47327592 | Epitope Mapping of SERCA2a Identifies an Antigenic Determinant That Induces Mainly Atrial Myocarditis in A/J Mice. |
| Q26799163 | Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate |
| Q64087382 | Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature |
| Q91776392 | Glucocorticoid-sensitive Paroxysmal Atrial Fibrillation, Sick Sinus Syndrome, and Mitral Regurgitation in a Patient with Malignant Rheumatoid Vasculitis |
| Q55251879 | High mobility group box 1 was associated with thrombosis in patients with atrial fibrillation. |
| Q38365003 | High risk factors of atrial fibrillation in type 2 diabetes: results from the Chinese Kailuan study |
| Q36758752 | Hydroxyethyl starch 6%, 130/0.4 vs. a balanced crystalloid solution in cardiopulmonary bypass priming: a randomized, prospective study |
| Q112282151 | Identification of Atrial Fibrillation-Related lncRNA Based on Bioinformatic Analysis |
| Q90724764 | Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation |
| Q34921180 | Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study) |
| Q36976052 | Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy |
| Q87690394 | Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison between abdominal aortic aneurysm and arrhythmia |
| Q35940899 | Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation |
| Q55171550 | Increased Risk of Atrial Fibrillation in the Early Period after Herpes Zoster Infection: a Nationwide Population-based Case-control Study. |
| Q64987571 | Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. |
| Q92968033 | Individualised Approaches for Catheter Ablation of AF: Patient Selection and Procedural Endpoints |
| Q38233801 | Inflammation and arrhythmias: potential mechanisms and clinical implications. |
| Q35158212 | Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) study |
| Q38333088 | Inflammation and the pathogenesis of atrial fibrillation. |
| Q88393065 | Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices |
| Q59807010 | Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases |
| Q48220780 | Inflammatory biomarkers in atrial fibrillation: are they linked to future outcomes? |
| Q89518990 | Inflammatory cell infiltration in left atrial appendageal tissues of patients with atrial fibrillation and sinus rhythm |
| Q39094801 | Influence of Inflammation and Atherosclerosis in Atrial Fibrillation |
| Q55029218 | Influence of ethnic background on left atrial markers of inflammation, endothelial function and tissue remodelling. |
| Q49231983 | Influenza vaccination might reduce the risk of ischemic stroke in patients with atrial fibrillation: A population-based cohort study. |
| Q88921640 | International Normalized Ratio Relevance to the Observed Coagulation Abnormalities in Warfarin Treatment and Disseminated Intravascular Coagulation |
| Q47910392 | Involvement of ERK1/2 in Cx43 depression induced by macrophage migration inhibitory factor in atrial myocytes. |
| Q91793611 | Left Atrial Strain as Evaluated by Two-Dimensional Speckle Tracking Predicts Left Atrial Appendage Dysfunction in Chinese Patients with Atrial Fibrillation |
| Q98153787 | Lipid levels and risk of new-onset atrial fibrillation: A systematic review and dose-response meta-analysis |
| Q54961675 | Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation. |
| Q64089069 | Low-Carbohydrate Diets and Risk of Incident Atrial Fibrillation: A Prospective Cohort Study |
| Q37709192 | Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population |
| Q37115524 | Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation |
| Q48092580 | Mechanisms of atrial fibrillation in athletes: what we know and what we do not know |
| Q42149657 | Molecular Mechanisms and New Treatment Paradigm for Atrial Fibrillation |
| Q36458845 | Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion. |
| Q39897313 | Neopterin and interleukin-6 as predictors of recurrent atrial fibrillation. |
| Q33675914 | Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias |
| Q35841934 | Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study). |
| Q38773385 | Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker? |
| Q26771542 | Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation |
| Q64277898 | Plasma Dimethylarginine Levels and Carotid Intima-Media Thickness are related to Atrial Fibrillation in Patients with Embolic Stroke |
| Q41002506 | Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease |
| Q57496719 | Plasma markers of myocardial inflammation at isolated atrial fibrillation |
| Q51135389 | Plasma oxidative stress and inflammatory biomarkers are associated with the sizes of the left atrium and pulmonary vein in atrial fibrillation patients. |
| Q93187570 | Predictors of recurrence of paroxysmal atrial fibrillation following cryoablation based pulmonary vein isolation |
| Q36306317 | Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population |
| Q38612651 | Prevention of Stroke in Rheumatoid Arthritis |
| Q50447798 | Protective effects of epigallocatechin-3 gallate on atrial electrical and structural remodeling in a rabbit rapid atrial pacing model. |
| Q41108699 | Proteinuria Detected by Urine Dipstick Test as a Risk Factor for Atrial Fibrillation: A Nationwide Population-Based Study |
| Q62666876 | Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study |
| Q37382789 | Randomized controlled trial of remote ischemic preconditioning and atrial fibrillation in patients undergoing cardiac surgery. |
| Q90732513 | Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented Rats |
| Q26775708 | Red blood cell distribution width and cardiovascular diseases |
| Q41686529 | Red blood cell distribution width predicts outcome of cryoballoon-based atrial fibrillation ablation |
| Q35884552 | Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells. |
| Q47154963 | Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis |
| Q35223168 | Relationship between brain natriuretic peptides and recurrence of atrial fibrillation after successful direct current cardioversion: a meta-analysis. |
| Q48763596 | Right atrial diameter and outcome of catheter ablation of atrial fibrillation |
| Q36178661 | Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study. |
| Q38732470 | Risk of incident atrial fibrillation in gout: a cohort study. |
| Q50561634 | Risk of thromboembolism and fatal stroke in patients with psoriasis and nonvalvular atrial fibrillation: a Danish nationwide cohort study. |
| Q90722766 | Risk of thromboembolism in patients developing critical illness-associated atrial fibrillation |
| Q58726183 | Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation |
| Q55209746 | Role of Red Cell Distribution Width in the Relationship between Clinical Outcomes and Anticoagulation Response in Patients with Atrial Fibrillation. |
| Q35688023 | Role of inflammation in atrial fibrillation pathophysiology and management. |
| Q58131502 | Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices |
| Q40961876 | Routine 18F-FDG PET/CT does not detect inflammation in the left atrium in patients with atrial fibrillation |
| Q33936957 | Scarcity of atrial fibrillation in a traditional African population: a community-based study |
| Q36321530 | Serum levels of nicotinamide-adenine dinucleotide phosphate oxidase 4 are associated with non-valvular atrial fibrillation |
| Q39300358 | Severe Spontaneous Echo Contrast/Auricolar Thrombosis in "Nonvalvular" AF: Value of Thromboembolic Risk Scores |
| Q55489498 | Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation. |
| Q64119729 | Stroke risk stratification in atrial fibrillation: a review of common risk factors |
| Q35810269 | Synthetic Oligodeoxynucleotides Containing Multiple Telemeric TTAGGG Motifs Suppress Inflammasome Activity in Macrophages Subjected to Oxygen and Glucose Deprivation and Reduce Ischemic Brain Injury in Stroke-Prone Spontaneously Hypertensive Rats |
| Q92688929 | Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression |
| Q38766654 | Systemic Inflammation and Arrhythmogenesis: A Review of Mechanistic and Clinical Perspectives |
| Q36680017 | Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment With an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation With Continuous Monitoring (REACT.COM) Pilot Study |
| Q92178623 | The Impact of Metabolic Syndrome on the Incidence of Atrial Fibrillation: A Nationwide Longitudinal Cohort Study in South Korea |
| Q64248997 | The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia |
| Q94606035 | The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study |
| Q40768590 | The associations of leptin, adiponectin and resistin with incident atrial fibrillation in women |
| Q90353557 | The imminent epidemic of atrial fibrillation and its concomitant diseases - Myocardial infarction and heart failure - A cause for concern |
| Q38224058 | The impact of atrial fibrillation and its treatment on dementia |
| Q92054911 | The prognostic value of postoperative blood glucose in non-diabetic patients with rheumatic heart disease |
| Q40906546 | The relationship between erectile dysfunction and paroxysmal lone atrial fibrillation. |
| Q37236227 | The risk of atrial fibrillation in patients with gout: a nationwide population-based study |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q91867453 | The role of immune cells in atrial fibrillation |
| Q53017670 | The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis. |
| Q51253660 | The use of monocyte to HDL ratio to predict postoperative atrial fibrillation after aortocoronary bypass graft surgery. |
| Q50986493 | Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression. |
| Q37639726 | Total adiponectin is inversely associated with platelet activation and CHA₂DS₂-VASc score in anticoagulated patients with atrial fibrillation. |
| Q90698920 | Transient outward K+ current can strongly modulate action potential duration and initiate alternans in the human atrium |
| Q46168398 | Tumour necrosis factor-α antagonism: a potential therapeutic target for prevention of arrhythmogenesis in the setting of acute myocardial infarction? |
| Q89408007 | Usefulness of the Addition of Renal Function to the CHA2DS2-VASc Score as a Predictor of Thromboembolism and Mortality in Patients Without Atrial Fibrillation |
| Q89910412 | Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats |
| Q26864437 | What do we currently know about metabolic syndrome and atrial fibrillation? |
| Q88412509 | [New onset atrial fibrillation in patients with sepsis] |
| Q36714040 | γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study |
Search more.